CN115969938B - 一种用于抑制由猪链球菌感染引起igf-1r转录水平上调的中药方剂的制备方法 - Google Patents
一种用于抑制由猪链球菌感染引起igf-1r转录水平上调的中药方剂的制备方法 Download PDFInfo
- Publication number
- CN115969938B CN115969938B CN202211240652.3A CN202211240652A CN115969938B CN 115969938 B CN115969938 B CN 115969938B CN 202211240652 A CN202211240652 A CN 202211240652A CN 115969938 B CN115969938 B CN 115969938B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- streptococcus suis
- mice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 133
- 238000013518 transcription Methods 0.000 title claims abstract description 20
- 230000035897 transcription Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 206010061372 Streptococcal infection Diseases 0.000 title claims abstract description 17
- 230000003827 upregulation Effects 0.000 title claims abstract description 15
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000012153 distilled water Substances 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims abstract description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 11
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 5
- 241000334154 Isatis tinctoria Species 0.000 claims abstract description 5
- 238000009835 boiling Methods 0.000 claims abstract description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 5
- 235000011477 liquorice Nutrition 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 5
- 240000008537 Burchellia bubalina Species 0.000 claims abstract description 4
- 235000004415 Burchellia bubalina Nutrition 0.000 claims abstract description 4
- 241000305491 Gastrodia elata Species 0.000 claims abstract description 4
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 4
- 241000157352 Uncaria Species 0.000 claims abstract description 4
- 230000005484 gravity Effects 0.000 claims abstract description 3
- 238000002390 rotary evaporation Methods 0.000 claims abstract description 3
- 240000001972 Gardenia jasminoides Species 0.000 claims abstract 3
- 241000194021 Streptococcus suis Species 0.000 claims description 33
- 201000009906 Meningitis Diseases 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 5
- 230000002222 downregulating effect Effects 0.000 claims description 3
- 238000001727 in vivo Methods 0.000 claims description 3
- 238000010874 in vitro model Methods 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 2
- 238000011282 treatment Methods 0.000 abstract description 42
- 241000282898 Sus scrofa Species 0.000 abstract description 3
- 238000007877 drug screening Methods 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 81
- JLDCNMJPBBKAHH-UHFFFAOYSA-N sodium;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide Chemical compound [Na+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 JLDCNMJPBBKAHH-UHFFFAOYSA-N 0.000 description 50
- 229960001182 sulfadiazine sodium Drugs 0.000 description 50
- 210000005013 brain tissue Anatomy 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 29
- 239000000243 solution Substances 0.000 description 20
- 239000000843 powder Substances 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 14
- 239000010413 mother solution Substances 0.000 description 14
- 208000015181 infectious disease Diseases 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 11
- 238000003753 real-time PCR Methods 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000012091 fetal bovine serum Substances 0.000 description 9
- 230000035699 permeability Effects 0.000 description 9
- 230000008499 blood brain barrier function Effects 0.000 description 8
- 210000001218 blood-brain barrier Anatomy 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 229960003699 evans blue Drugs 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 230000002757 inflammatory effect Effects 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 206010059866 Drug resistance Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 108010019160 Pancreatin Proteins 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000007640 basal medium Substances 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 229940055695 pancreatin Drugs 0.000 description 6
- 238000010839 reverse transcription Methods 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 241000282887 Suidae Species 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 206010015866 Extravasation Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 229930182816 L-glutamine Natural products 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000001045 blue dye Substances 0.000 description 3
- 238000011284 combination treatment Methods 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 230000036251 extravasation Effects 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229940054269 sodium pyruvate Drugs 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 244000111489 Gardenia augusta Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000002987 choroid plexus Anatomy 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000003640 drug residue Substances 0.000 description 2
- 206010014665 endocarditis Diseases 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 210000002418 meninge Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- PAVKBQLPQCDVNI-UHFFFAOYSA-N n',n'-diethyl-n-(9-methoxy-5,11-dimethyl-6h-pyrido[4,3-b]carbazol-1-yl)propane-1,3-diamine Chemical compound N1C2=CC=C(OC)C=C2C2=C1C(C)=C1C=CN=C(NCCCN(CC)CC)C1=C2C PAVKBQLPQCDVNI-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000027954 Poultry disease Diseases 0.000 description 1
- 102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 102000004584 Somatomedin Receptors Human genes 0.000 description 1
- 108010017622 Somatomedin Receptors Proteins 0.000 description 1
- 208000017757 Streptococcal toxic-shock syndrome Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000003654 cell permeability assay Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 210000004289 cerebral ventricle Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000214 effect on organisms Effects 0.000 description 1
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- IYWCBYFJFZCCGV-UHFFFAOYSA-N formamide;hydrate Chemical compound O.NC=O IYWCBYFJFZCCGV-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 239000012674 herbal formulation Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 210000004924 lung microvascular endothelial cell Anatomy 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000004925 microvascular endothelial cell Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000006654 negative regulation of apoptotic process Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- 229960001237 podophyllotoxin Drugs 0.000 description 1
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000009374 poultry farming Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 244000000023 zoonotic pathogen Species 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211240652.3A CN115969938B (zh) | 2022-10-11 | 2022-10-11 | 一种用于抑制由猪链球菌感染引起igf-1r转录水平上调的中药方剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211240652.3A CN115969938B (zh) | 2022-10-11 | 2022-10-11 | 一种用于抑制由猪链球菌感染引起igf-1r转录水平上调的中药方剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115969938A CN115969938A (zh) | 2023-04-18 |
CN115969938B true CN115969938B (zh) | 2024-03-26 |
Family
ID=85966942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211240652.3A Active CN115969938B (zh) | 2022-10-11 | 2022-10-11 | 一种用于抑制由猪链球菌感染引起igf-1r转录水平上调的中药方剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115969938B (zh) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100628700B1 (ko) * | 2005-07-04 | 2006-10-02 | 피더블유제네틱스코리아 주식회사 | 실험용 특정 병원균 부재 소형 돼지의 생산방법 |
WO2010042970A1 (en) * | 2008-10-15 | 2010-04-22 | Pork Crc Ltd | A method of vaccination pigs |
CN101797342A (zh) * | 2010-04-22 | 2010-08-11 | 王玉兰 | 一种治疗风湿类风湿性关节炎的中药 |
CN102258620A (zh) * | 2011-07-21 | 2011-11-30 | 赵志敏 | 治疗猪链球菌和猪瘟混合感染的中药注射剂及其制备方法 |
CN102631579A (zh) * | 2012-04-18 | 2012-08-15 | 中国人民解放军第三医院 | 一种治疗脑外伤后综合征的口服中药制剂 |
CN104352813A (zh) * | 2014-10-30 | 2015-02-18 | 张运鹏 | 一种用于治疗类风湿关节炎及腰椎间盘突出的中药水丸 |
CN104771518A (zh) * | 2015-04-30 | 2015-07-15 | 成都乾坤动物药业有限公司 | 一种抗炎、治疗或辅助治疗猪发热病的药物组合物及其制备方法 |
CN105311423A (zh) * | 2014-07-15 | 2016-02-10 | 王艳 | 治疗眩晕症的中药组合物 |
CN105902638A (zh) * | 2016-06-04 | 2016-08-31 | 郑堂勇 | 一种防治猪链球菌病的中草药复方 |
CN106109762A (zh) * | 2016-08-29 | 2016-11-16 | 广西大学 | 一种防治猪细菌性疾病的中药制剂及其制备方法 |
CN107184824A (zh) * | 2017-04-13 | 2017-09-22 | 防城港市动物疫病预防控制中心 | 一种防治猪细菌性疾病的中药制剂及其制备方法 |
CN111991515A (zh) * | 2020-09-08 | 2020-11-27 | 贵州中医药大学第一附属医院 | 一种治疗阴虚风动证型中风病的中药组合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190116833A1 (en) * | 2017-10-23 | 2019-04-25 | Nutriquest, Llc | Feed additive compositions |
-
2022
- 2022-10-11 CN CN202211240652.3A patent/CN115969938B/zh active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100628700B1 (ko) * | 2005-07-04 | 2006-10-02 | 피더블유제네틱스코리아 주식회사 | 실험용 특정 병원균 부재 소형 돼지의 생산방법 |
WO2010042970A1 (en) * | 2008-10-15 | 2010-04-22 | Pork Crc Ltd | A method of vaccination pigs |
CN101797342A (zh) * | 2010-04-22 | 2010-08-11 | 王玉兰 | 一种治疗风湿类风湿性关节炎的中药 |
CN102258620A (zh) * | 2011-07-21 | 2011-11-30 | 赵志敏 | 治疗猪链球菌和猪瘟混合感染的中药注射剂及其制备方法 |
CN102631579A (zh) * | 2012-04-18 | 2012-08-15 | 中国人民解放军第三医院 | 一种治疗脑外伤后综合征的口服中药制剂 |
CN105311423A (zh) * | 2014-07-15 | 2016-02-10 | 王艳 | 治疗眩晕症的中药组合物 |
CN104352813A (zh) * | 2014-10-30 | 2015-02-18 | 张运鹏 | 一种用于治疗类风湿关节炎及腰椎间盘突出的中药水丸 |
CN104771518A (zh) * | 2015-04-30 | 2015-07-15 | 成都乾坤动物药业有限公司 | 一种抗炎、治疗或辅助治疗猪发热病的药物组合物及其制备方法 |
CN105902638A (zh) * | 2016-06-04 | 2016-08-31 | 郑堂勇 | 一种防治猪链球菌病的中草药复方 |
CN106109762A (zh) * | 2016-08-29 | 2016-11-16 | 广西大学 | 一种防治猪细菌性疾病的中药制剂及其制备方法 |
CN107184824A (zh) * | 2017-04-13 | 2017-09-22 | 防城港市动物疫病预防控制中心 | 一种防治猪细菌性疾病的中药制剂及其制备方法 |
CN111991515A (zh) * | 2020-09-08 | 2020-11-27 | 贵州中医药大学第一附属医院 | 一种治疗阴虚风动证型中风病的中药组合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
Identification and Experimental Verification of Protective Antigens Against Streptococcus suis Serotype 2 Based on Genome Sequence Analysis;Lina Liu;Curr Microbiol;第58卷;11-17 * |
中草药在防治猪病上的应用;张保平;今日畜牧兽医(第7期);151-17 * |
探究中草药在防治猪传染病上的临床应用;李元亮;中国畜禽种业;第18卷(第06期);152-153 * |
Also Published As
Publication number | Publication date |
---|---|
CN115969938A (zh) | 2023-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105012349A (zh) | 一种防治血管性痴呆的益生菌制剂及其制备方法 | |
CN106924477B (zh) | 一种混合菌发酵生产的复合中药发酵制剂及其制备方法 | |
CN103223021A (zh) | 防治奶牛、母猪子宫内膜炎的子宫灌注药物及制备方法 | |
CN115969938B (zh) | 一种用于抑制由猪链球菌感染引起igf-1r转录水平上调的中药方剂的制备方法 | |
CN101862366B (zh) | 从骆驼刺植物中提取治疗过敏性结肠炎药物的方法及其药物和用途 | |
CN106728038A (zh) | 一种防治水产动物肝胆疾病的中药饲料预混剂及其制备方法 | |
CN109966357A (zh) | 一种中药微生态复方制剂及其制备方法和应用 | |
CN103191356B (zh) | 抗菌喷剂及其制备方法 | |
CN106619887B (zh) | 抑杀舒伯特单胞菌的复方中药制剂、制备方法及其应用 | |
CN107586746A (zh) | 一株具有防治奶牛乳房炎功效的乳酸菌及其应用 | |
CN109602859B (zh) | 苗药廖氏化风丹在制备防治黑色素瘤药物中的应用 | |
CN109316533B (zh) | 一种清除猪体内毒素的发酵中药复方制剂及其应用 | |
CN112791037A (zh) | 一种组合活性物及其制备方法和其在制备舒缓皮肤过敏的产品或药物中的应用 | |
CN106074668B (zh) | 用于神经退行性疾病或神经再生的中药制剂 | |
CN101366852B (zh) | 治疗鸭疫里氏杆菌病的中草药物及其制备方法 | |
CN110917287A (zh) | 一种药用植物提取物 | |
CN100497650C (zh) | 一种富锌亮菌多糖及其制备方法和用途 | |
CN110403993A (zh) | 一种复方白头翁散的配方方剂及其应用 | |
CN108815239A (zh) | 一种药物组合物在制备抗菌药物中的应用 | |
CN103271983A (zh) | 一种治疗猪的子宫内膜炎和阴道炎的灌注液、其制备方法和应用 | |
CN113679703B (zh) | 甘草查尔酮a在抗水产养殖动物嗜水气单胞菌感染中的应用 | |
CN113694096B (zh) | 一种甘草提取物及其制备方法和应用 | |
CN104688823B (zh) | 一种抗菌消炎止痒的中药组合物及其制备方法 | |
CN113499328B (zh) | 甘草查尔酮a在制备抗艰难梭菌感染药物中的应用 | |
CN114224989B (zh) | 一种抗幽门螺杆菌的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Jin Hui Inventor after: Xu Qianshuai Inventor after: Gong Huimin Inventor after: Sun Yu Inventor after: Wang Mingyang Inventor after: Ma Bin Inventor after: Guan Aohan Inventor after: Gao Yuan Inventor after: Chen Liying Inventor after: Wang Dehai Inventor after: Hu Xueying Inventor after: Shi Deshi Inventor after: Xiao Yuncai Inventor after: He Yanling Inventor after: Hua Kexin Inventor after: Wang Haoyu Inventor before: Jin Hui Inventor before: Xu Qianshuai Inventor before: Gong Huimin Inventor before: Sun Yu Inventor before: Wang Mingyang Inventor before: Ma Bin Inventor before: Guan Aohan Inventor before: Gao Yuan Inventor before: Chen Liying Inventor before: Wang Dehai Inventor before: Hu Xueying Inventor before: Shi Deshi Inventor before: Xiao Yuncai Inventor before: He Yanling Inventor before: Hua Kexin Inventor before: Wang Haoyu |
|
CB03 | Change of inventor or designer information |